OCULAR GRAFT-VERSUS-HOST DISEASE
Clinical trials for OCULAR GRAFT-VERSUS-HOST DISEASE explained in plain language.
Never miss a new study
Get alerted when new OCULAR GRAFT-VERSUS-HOST DISEASE trials appear
Sign up with your email to follow new studies for OCULAR GRAFT-VERSUS-HOST DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New eye drop offers hope for dry eye in transplant patients
Symptom relief Recruiting nowThis study tests an experimental eye drop (rhPRG4) to see if it safely eases dry eye symptoms in people with ocular graft-versus-host disease (oGVHD), a complication after bone marrow transplant. About 15 adults with moderate to severe dry eye will receive both the active drop an…
Matched conditions: OCULAR GRAFT-VERSUS-HOST DISEASE
Phase: PHASE2 • Sponsor: Lubris Bio Pty Ltd • Aim: Symptom relief
Last updated Jun 27, 2026 08:12 UTC
-
Scientists hunt for biomarkers to unlock rare eye disease treatments
Knowledge-focused Recruiting nowThis study aims to find biological markers (biomarkers) in blood, tears, and eye cells from 110 adults with seven rare eye diseases. Researchers will compare these markers between patients and healthy controls to see if they differ and if they relate to disease symptoms. The goal…
Matched conditions: OCULAR GRAFT-VERSUS-HOST DISEASE
Phase: NA • Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Jul 09, 2026 00:00 UTC